© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
Sierra Nevada Corporation Acquires Kutta Technologies, Inc. to Expand its Unmanned Technologies
M&A
29/04/2015Sierra Nevada Corporation Acquires Kutta Technologies, Inc. to Expand its Unmanned Technologies

Sierra Nevada Corporation (SNC) announces the successful acquisition of its newest wholly-owned subsidiary, Kutta Technologies, Inc. (Kutta) located in Phoenix, Arizona.

Read Full PostRead - Eye Icon
Creating an Effective Crisis Communication Plan in 2024
News
15/04/2024Creating an Effective Crisis Communication Plan in 2024

Having a solid crisis communication plan is determining for organizations In today’s business climate. With only 49% of U.S. companies possessing a formal plan in 2023, it became increasingly evident that businesses need to be prepared for worst-case sce

Read Full PostRead - Eye Icon
Maritime Tech Pioneer Orca AI Unveils New Version of SeaPod Digital Watchkeeping Unit
Innovation
21/02/2024Maritime Tech Pioneer Orca AI Unveils New Version of SeaPod Digital Watchkeeping Unit

Orca AI’s SeaPod acts as a fully automated navigational assistant that processes multiple sources of information in seconds, mimicking and enhancing human watchkeeping 24/7 to identify and evaluate the most complex marine traffic situations in real time.

Read Full PostRead - Eye Icon
Most Innovative Accountancy Firms of 2016, UK
Finance
01/07/2016Most Innovative Accountancy Firms of 2016, UK

Accountancy 4 Wealth Ltd is based in Staffordshire, with 4 offices. They are a chartered accountancy practice which helps clients of all sizes to use their accounts as a basis to grow their business.

Read Full PostRead - Eye Icon
Investors Urged to Invest Overseas to Mitigate Risks Posed by UKIP Gains
Finance
23/02/2015Investors Urged to Invest Overseas to Mitigate Risks Posed by UKIP Gains

Investors need to take precautions against a fall in the value of UK assets, which may be triggered by UKIP gains at the polls.

Read Full PostRead - Eye Icon
A Presence Within the Middle East
Strategy
26/01/2017A Presence Within the Middle East

A dominant and resilient presence within the architecture world of the Middle East since its founding in 1984, the National Engineering Bureau has consistently and steadily carved out a reputation to match its many successful architecting feats across the regi

Read Full PostRead - Eye Icon
Automated Workflow Project of the Year: COBRA
Finance
01/07/2016Automated Workflow Project of the Year: COBRA

Brock Walker is the Acting Director of the Shared Services Program (SSP) at the Department of the Treasury. In this role, he manages a small team responsible for the direct corporate budget oversight over the $228+ million Shared Services Program.

Read Full PostRead - Eye Icon
How to Start a Publishing Company: 8 Important Steps
News
09/08/2024How to Start a Publishing Company: 8 Important Steps

Creative freedom, increased clout, and potential profit. These three reasons to start your own publishing company may fuel your decision to take that step, but they do little to help you understand everything that goes into it. Writers who choose to self-publi

Read Full PostRead - Eye Icon
Not Losing Interest
Finance
13/02/2017Not Losing Interest

Cavmont Bank Ltd’s vision is to be a world class bank rated amongst the best in Zambia with a focus on partnering with all their stakeholders. Following their success in winning the 2016 Banker of the Year Zambia



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow